A method for the quantitative determination of leucogenenol, a leucocytosis-inducing compound produced by Penicillium gilmanii, has been developed. The formation of leucogenenol in P. gilmanii and its diffusion into the culture fluid has been followed over a period of 12 weeks. The highest concentration of leucogenenol was found in the mycelium of rapidly growing cultures. The greatest concentration occurred in the culture fluid, however, after cessation of rapid growth. The concentration of leucogenenol in the mycelium of cultures over 4 weeks old fluctuated widely. This fluctuation was apparently due to the formation and rapid growth of daughter colonies.
In a previous communication, it was reported that the intravenous injection into rabbits of 0.01 ml of the culture fluid from a surface culture of Penicillium gilmanii grown on a Czapek-Dox medium (1) caused the animals to develop leucocytosis and hyperpyrexia (2). It was also reported (2) that the two biological phenomena were due to two separate metabolites. These biologically active metabolites could be separated from each other by their difference in relative solubilities in ether and water. Lastly, a method was reported for isolating the substance that caused the leucocytosis as a chromatographically homogeneous compound of probable molecular formula, C18H29_3, NO9. The name leucogenenol was suggested for the compound.
The yields of leucogenenol were relatively low (3 to 15 mg per liter of culture medium) and varied considerably in 3-to 6-week-old cultures. It became of interest, therefore, to determine the growth period that would provide the highest concentration of leucogenenol in the culture fluid and also to study the concentration of leucogenenol in the mycelium itself.
Since there was no readily apparent quantitative relationship between the biological response and the quantity of leucogenenol injected (F. A. H. Rice, in preparation), it was necessary to devise a chemical method of assay, which is reported in this paper.
Although only one compound in the culture medium, leucogenenol, had shown any ability to affect the leukocyte count in animals, it did not follow that this would necessarily be true of the compounds extractable from the mycelium. It was possible, for example, that leucogenenol was formed in the mycelium as a somewhat different chemical entity that was transformed by enzymatic or other action into leucogenenol after it had diffused into the culture medium. If either or both of the above possibilities were true, an assay method based only on the chemical determination of leucogenenol as found in the culture medium might lead to erroneous results when applied to mycelium. Accordingly, it was necessary to find out whether or not leucogenenol could be found in the mycelium before a chemical method of assay could be developed.
MATERIALS AND METHODS
Identification of leucogenenol in the mycelia. Mycelia from surface cultures of P. gilmanii grown on Czapek-Dox media (1) were selected at random from 2-to 6-week-old cultures and were dried over anhydrous CaCI2 at 0.2 mm of Hg. The mycelia were powdered and extracted with redistilled methanol in a Soxhlet extractor for 8 hr. The methanol extract was evaporated to dryness at 40 to 50 C under reduced pressure and was redissolved in 100 ml of distilled water. At this point, the residue from 0.1 ml of the extract dissolved in 100 ml of pyrogen-free saline (Cutter Laboratories, Berkeley, Calif.) induced a leucocytosis when 0.2 ml of the saline solution was injected into each of six rabbits (2). The aqueous solution was extracted twice with 100 ml of ether, and the aqueous phase was then carried through the procedure for isolating leucogenenol from the culture fluid (2). Thin-layer chromatography (2) and comparison of the infrared spectra (2) showed that the product from the mycelia was identical with the leucogenenol isolated from the culture fluid.
Medium and culture preparation. A 100-ml amount of Czapek-Dox culture medium was added to each of forty-eight 250-ml Erlenmeyer flasks. The flasks were allowed to stand at room temperature (25 i 2 C). At intervals, two flasks were taken and the mycelium was separated from the culture fluid by filtration on Whatman no. 1 filter paper in a glass funnel. The mycelium from each flask was separately washed with approximately 10 ml of distilled water, and the excess water was removed by pressing the mass between paper towels. The mycelium was dried under reduced pressure (0.2 mm of Hg) in a desiccator over anhydrous CaCl2 for over 24 hr and was weighed (Fig. 1) .
Ultraviolet-absorption spectra of leucogenenol. The absorption spectra of weighed quantities of leucogenenol (as the calcium salt) were determined on a Beckman DBG spectrophotometer. The absorption spectra based on the calculated quantities of free leucogenenol are shown in Fig. 2 .
Determination of leucogenenol in the culture fluid. After measuring the pH of the culture fluid (Fig. 3) , the media from two flasks were combined and continuously extracted with initially anhydrous reagentgrade ether in a continuous liquid-liquid extractor of 250-ml capacity for 8 hr. The aqueous phase was then poured through 20 g of Amberlite (Rohm and Haas Co., Philadelphia, Pa.) IR-120 in the acid form. The Amberlite was washed with at least 300 ml of distilled water, or until the filtrate was colorless. The filtrate from the Amberlite was poured through a column, (2 by 36 cm) of Amberlite IR-45 (in the alkaline form). The column was first washed with the washings of the Amberlite IR-120 and then with at least 1,500 ml of distilled water. The column was then Mycelium from surface culture in 250-ml Erlenmeyer flask containing 100 ml of culture medium. Approximate diameter of mycelium, 7.5 cm. Time as indicated. eluted with 30 ml of 3% ammonia-water followed by 300 ml of distilled water. The combined eluate was concentrated to dryness under reduced pressure at a temperature of 40 to 50 C. The dry residue was extracted overnight with methanol (30 ml), and the residue was further washed with methanol (twice, 30 ml). The combined methanol extracts were treated with 0.5 g of Pb (OAc)2*3H20, stirred for 5 to 10 min, and then filtered through a fritted-glass filter. The residue was washed with 25 ml of methanol. The filtrate was treated with H2S and filtered through Whatman no. 1 filter paper, and the residue was washed with 25 ml of methanol. The combined filtrates were evaporated to dryness under reduced pressure at 40 to 50 C.
The resulting semicrystalline mass was extracted with 10 ml of n-propyl alcohol and filtered; the insoluble portion was washed with n-propyl alcohol (twice, 5 ml). The filtrates were combined, diluted 1:1 with methanol, and passed through a column (1 by 22 cm) of Amberlyst 15 (in the acid form) kindly supplied by the Rohm and Haas Co. The filtrates were collected in a flask containing 0.5 g of PbCO3. The resins were recycled and washed several times before use. The Amberlyst was washed with 100 ml of methanol, and the combined filtrates from the column were evaporated to dryness under reduced pressure at 40 to 50 C. The resulting residue (a syrup) was then extracted with dioxane (10 ml + 5 ml, twice) and filtered through Whatman no. 1 filter paper. VOL. 15, 1967 791 ai RICE AND BARROW The filtrate was treated with H2S, refiltered, and washed twice with 5 ml of dioxane. The dioxane solution was evaporated to a syrup under reduced pressure at 40 to 50 C. It was then extracted three times with 10 ml of anhydrous ether and filtered through Whatman no. 541 filter paper. The ether extract was then chromatographed on a column (6 by 1 cm) containing 5 g of silicic acid (Fisher Scientific, Pittsburgh, Pa.; precipitated) . The column was washed with 150 ml of anhydrous ether, followed by 150 ml of ethyl acetate, and then the leucogenenol was eluted with 100 ml of benzene containing 5% (v/v) methanol. The benzenemethanol eluate was filtered through a medium frittedglass filter, and the filter was washed with 100 ml of benzene containing 5% methanol (v/v). The combined filtrate was evaporated to dryness under reduced pressure at 40 to 50C, and the residue was further dried under high vacuum.
The dried residue was dissolved in 10 ml of distilled water added from a volumetric pipette, and the ultraviolet-absorption spectrum was determined continuously over the range of 200 to 320 m,u. Weighed quantities of leucogenenol (as the calcium salt), when carried through this procedure, were recovered in 98% yields.
Determination of leucogenenol in the mycelium. The weighted mycelia from two cultures were broken in small pieces, placed in a 25' by 80 mm thimble (J.
Green no. 703), and extracted in a Soxhlet extractor with approximately 100 ml of boiling methanol for 8 hr. The methanol extract was filtered through Whatman no. 1 filter paper, and the filtrate was passed through a column (2 by 50 cm) of Amberlyst-15 (in the acid form). The Amberlyst was then washed with 200 ml of methanol. The combined filtrates were evaporated to a syrup under reduced pressure at 40 to 50 C. The syrup was extracted with 15 ml of anhydrous ether and washed twice with 10 ml of ether. The ether extract was filtered through Whatman no. 541 filter paper and chromatographed on silicic acid. The concentration of leucogenenol was determined in the same manner as for the leucogenenol in the culture media.
The concentrations of leucogenenol in the mycelium and in the culture fluid were determined at weekly intervals over a 12-week period. The results are shown in Fig. 4 . Duplicate experiments yielded essentially the same results. Since it was known (2) that free leucogenenol as well as its salts with sodium, potassium, and ammonium were all soluble in methanol, and and insofar as sodium and potassium were the principal positive ions incorporated in the Czapek-Dox medium, it was considered that methanol should extract any leucogenenol from the mycelium if it were present either free or in an adsorbed form. It should then be possible to isolate and identify it by the previously reported procedure (2). Should a precursor rather than leucogenenol itself be present in the mycelium as a methanol-soluble compound, leucogenenol could not be isolated from the methanol extract. In the eventuality that a methanol-insoluble precursor to leucogenenol existed in the mycelium, it would have to be soluble in isotonic saline, in order to establish its presence by its biological on October 23, 2017 by guest http://aem.asm.org/ Downloaded from activity in animals. Therefore, only a methanol extraction of the mycelium, followed by an extraction with isotonic saline, was made. Only the methanol extract showed any biological activity. The methanol extract yielded, as the sole biologically active compound, a substance identical to leucogenenol when it was subjected to the reported isolation procedure (2).
It would appear, therefore, that leucogenenol is formed intracellularly by P. gilmanii and diffuses from the mycelium into the culture medium.
Several methods of assay based on the thinlayer separation of leucogenenol at early stages in the isolation procedure were investigated without success. The method eventually selected involved the actual isolation of leucogenenol as a chromatographic zone and the determination of its concentration by ultraviolet absorption. The final quantitative determination presented a slight difficulty because of the shape of the absorption curve. Figure 2 shows the ultraviolet absorption spectra of leucogenenol at two concentrations. Since the curves have no sharp maxima, it was necessary to determine the relationship between optical density and concentration at several wavelengths. The relationships were found to be: optical density/concentration (mg/ml) = 1.030, 1.054, and 1.285 at 264, 270, and 280 m,u, respectively. A comparison between calculated and found values is shown in Table 1 . Figure 4 shows that in the 1st week, a period during which there was a rapid growth of mycelium, a relatively large amount of leucogenenol was found in the mycelium, but only a small amount in the culture fluid. At the end of the second week, the quantity of leucogenenol in the mycelium decreased; however, a corresponding increase was not found in the culture fluid. The culture fluid, on the contrary, also showed a decrease in leucogenenol. At the end of 3 weeks, the leucogenenol in the mycelium increased and there was a corresponding increase in the concentration of leucogenenol in the culture fluid. After 6 weeks, the concentration of leucogenenol in the culture fluid remained relatively constant. The concentration of leucogenenol in the mold, however, showed considerable fluctuations. Interestingly enough, the cultures over 6 weeks old showed, in most cases, the secondary development of new areas of mycelium.
It would appear that leucogenenol, although produced as a metabolic product, is also utilized by the growing mycelium; otherwise, more than was found should collect in the culture fluid. Experience with 2-liter volumes of culture medium as used in isolating quantities of leucogenenol (2) indicates that leucogenenol does not decompose when it is stored for weeks in the filtered culture fluid. A comparison of Fig. 1 with Fig. 4 shows that during the rapid growth of the mycelium (first 4 weeks) leucogenenol is found in the mycelium, but little collects in the culture fluid. After the initial rapid growth, the weight of the mycelium decreases (probably due to autolysis taking place at a more rapid rate than the mycelium continues to grow); however, the concentration of leucogenenol in the culture fluid remains relatively constant. It is noteworthy that after 6 weeks the formation of daughter colonies is observed and the rapid growth of such colonies and their consequent formation of leucogenenol at an increased rate could account for the fluctuation in the concentration of leucogenenol observed in the mycelium.
A comparison of Fig. 2 and 4 shows that acidic compounds (among them leucogenenol; pK, 3.7) are produced in the first week. Since the pH then becomes less acidic, these compounds are either reused or corresponding quantities of basic compounds are produced during the second 2-week period. 
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